Combined effects of nifekalant and lidocaine on the spiral-type re-entry in a perfused 2-dimensional layer of rabbit ventricular myocardium.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Journal

• Publication date

  2005-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.69.576PMID 15849445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization.

  2004cited by this paper
• Shock-induced arrhythmogenesis is enhanced by 2,3-butanedione monoxime compared with cytochalasin D.

  2004cited by this paper
• Rotors and Spiral Waves in Two Dimensions

  2004cited by this paper
• Chapter 15 – Pharmacology of the Cardiac Sodium Channel

  2004cited by this paper
• Theory of Reentry

  2004cited by this paper
• [Changes in the management of cardiac arrest].

  2004cited by this paper
• A Tale of Two Fibrillations

  2003cited by this paper
• Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis.

  2003cited by this paper
• Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.

  2003cited by this paper
• [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].

  2003cited by this paper
• Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action.

  2002cited by this paper
• Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart.

  2001cited by this paper
• Density and Kinetics of IKr and IKs in Guinea Pig and Rabbit Ventricular Myocytes Explain Different Efficacy of IKs Blockade at High Heart Rate in Guinea Pig and Rabbit: Implications for Arrhythmogenesis in Humans

  2001cited by this paper
• Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles.

  2001cited by this paper
• Rectification of the Background Potassium Current: A Determinant of Rotor Dynamics in Ventricular Fibrillation

  2001cited by this paper
• Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction.

  2001cited by this paper
• New guidelines for cardiopulmonary resuscitation and emergency cardiac care: changes in the management of cardiac arrest.

  2001cited by this paper
• Preventing ventricular fibrillation by flattening cardiac restitution.

  2000cited by this paper
• Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

  2000cited by this paper
• Ventricular fibrillation: mechanisms of initiation and maintenance.

  2000cited by this paper
• High-frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart.

  2000cited by this paper
• Anisotropic Reentry in a Perfused 2-Dimensional Layer of Rabbit Ventricular Myocardium

  2000cited by this paper
• Ventricular Fibrillation: How Do We Stop the Waves From Breaking?

  2000cited by this paper
• Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation.

  1999cited by this paper
• Spiral waves in two-dimensional models of ventricular muscle: formation of a stationary core.

  1998cited by this paper
• Electropharmacology of Nifekalant, a New Class III Antiarrhythmic Drug

  1998cited by this paper
• Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?

  1997cited by this paper
• Role of wavefront curvature in propagation of cardiac impulse.

  1997cited by this paper
• Differential effects of MS-551 and E-4031 on action potentials and the delayed rectifier K+ current in rabbit ventricular myocytes.

  1996cited by this paper
• Inhibition of ATP-sensitive potassium channels in cardiac myocytes by the novel class III antiarrhythmic agent MS-551.

  1995cited by this paper
• Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

  1993cited by this paper
• Anisotropic conduction and reentry in perfused epicardium of rabbit left ventricle.

  1992cited by this paper

• The Virtual Electrode Hypothesis of Defibrillation

  2021cites this paper
• Validation of Intraoperative Catheter Phase Mapping Using a Simultaneous Optical Measurement System in Rabbit Ventricular Myocardium.

  2020cites this paper
• Nonlinear and Stochastic Dynamics in the Heart.

  2014cites this paper
• The role of gap junctions in stretch-induced atrial fibrillation

  2014cites this paper
• Chaos in the genesis and maintenance of cardiac arrhythmias.

  2011cites this paper
• Acute amiodarone promotes drift and early termination of spiral wave re-entry

  2010cites this paper
• Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm.

  2010cites this paper
• 院外心肺停止患者における電気的除細動抵抗性の心室頻拍・心室細動に対するリドカインとIII群抗不整脈薬の効果 : 臨床例と基礎的実験の検討から

  2009cites this paper
• Early termination of spiral wave reentry by combined blockade of Na+ and L-type Ca2+ currents in a perfused two-dimensional epicardial layer of rabbit ventricular myocardium.

  2009cites this paper
• Early termination of spiral wave reentry by combined blockade of Na[+] and L-type Ca[2+] currents in a perfused two-dimensional epicardial layer of rabbit ventricular myocardium

  2009cites this paper
• Low-frequency oscillations of atrial fibrillation cycle length in goats: characterization and potentiation by class III antiarrhythmic almokalant.

  2008cites this paper
• Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster.

  2008cites this paper
• Skuteczność terapii złożonej polegającej na podaniu blokera kanału IKr oraz wykonaniu blokady zwoju gwiaździstego w leczeniu opornych arytmii komorowych u chorych z zatrzymaniem krążenia

  2007cites this paper
• Pharmacological regulation of spiral wave reentry in the ventricle: Benefits and limitation of K channel blockers

  2007cites this paper
• JBO PRO O F CO PY 007704 JBO Three-dimensional panoramic imaging of cardiac arrhythmias in rabbit heart Fujian

  2007cites this paper
• Three-dimensional panoramic imaging of cardiac arrhythmias in rabbit heart.

  2007cites this paper
• Is the combination therapy of IKr-channel blocker and left stellate ganglion block effective for intractable ventricular arrhythmia in a cardiopulmonary arrest patient?

  2007cites this paper
• Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant.

  2007influential citation
• Modulation of spiral wave reentry by K(+) channel blockade.

  2007cites this paper
• Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? : comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis.

  2006cites this paper
• Nifekalant hydrochloride administration during cardiopulmonary resuscitation improves the transmural dispersion of myocardial repolarization: experimental study in a canine model of cardiopulmonary arrest.

  2006cites this paper
• Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.

  2006cites this paper
• Dynamics and Cardiac Arrhythmias

  2006cites this paper
• Virtual electrode hypothesis of defibrillation.

  2006cites this paper
• [Pharmacological modification of spiral-type reentry].

  2005cites this paper
• Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium.

  2005cites this paper